Peptide-drug Conjugate Information
General Information of This Peptide-drug Conjugate (PDC)
| PDC ID |
PDC_00105
|
|||||
|---|---|---|---|---|---|---|
| PDC Name |
Cytolysin[F7,P34]-NPY bioconjugate
|
|||||
| PDC Status |
Investigative
|
|||||
| Indication |
In total 1 Indication(s)
Breast cancer
|
|||||
| Structure |
|
|||||
| Peptide Name |
[K4,F7,K22,P34]-NPY
|
Peptide Info | ||||
| Receptor Name |
Neuropeptide Y receptor type 1 (NPY1R)
|
Receptor Info | ||||
| Drug Name |
Cytolysin-dithiopyridine
|
Drug Info | ||||
| Linker Name |
Disulfide bond
|
Linker Info | ||||
| Formula |
C246H368FN61O63S3
|
|||||
| #Ro5 Violations (Lipinski): 5 | Molecular Weight | 5303.213 | ||||
| Lipid-water partition coefficient (xlogp) | -7.9121 | |||||
| Hydrogen Bond Donor Count (hbonddonor) | 61 | |||||
| Hydrogen Bond Acceptor Count (hbondacc) | 70 | |||||
| Rotatable Bond Count (rotbonds) | 170 | |||||
Full List of Activity Data of This Peptide-drug Conjugate
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Data of This PDC | [1] | ||||
| Indication | Breast cancer | ||||
| Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
236.1 nM
|
|||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-468 cell | CVCL_0419 | ||
| Experiment 2 Reporting the Activity Data of This PDC | [1] | ||||
| Indication | Breast cancer | ||||
| Efficacy Data | Half Maximal Inhibitory Concentration (IC50) |
405.3 nM
|
|||
| In Vitro Model | Invasive breast carcinoma | MCF-7 cell | CVCL_0031 | ||
References